Last reviewed · How we verify
Acyl ghrelin
At a glance
| Generic name | Acyl ghrelin |
|---|---|
| Also known as | Human acyl ghrelin, Ghrelin |
| Sponsor | Esben Thyssen Vestergaard |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Increased Appetite
- Somnolence
- Euphoric mood
- Fatigue
- Dizziness
- Nausea
- Hyperhidrosis
- Memory impairment
- Decreased appetite
- Feeling hot
- Flushing
- Headache
Key clinical trials
- Effects of Ghrelin Administration on Motivation (NA)
- Nutrient Sensing in the Duodenum (PHASE1)
- Physiological Responses to Laparoscopic Sleeve Gastrectomy: Focusing on Ghrelin (NA)
- Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome (PHASE2, PHASE3)
- Effects of a 12-week Combined Exercise Program on Ghrelins in Obese Adolescent Girls (NA)
- Investigating the Role of Ghrelin in Regulating Appetite and Energy Intake in Patients Following Bariatric Surgery (BARI-INSIGHT) (NA)
- Effect of Ghrelin on Decision-Making (PHASE1)
- Preprandial Ghrelin Effect (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Acyl ghrelin CI brief — competitive landscape report
- Acyl ghrelin updates RSS · CI watch RSS
- Esben Thyssen Vestergaard portfolio CI